Serum tumor markers expression (CA199, CA242, and CEA) and its clinical implications in type 2 diabetes mellitus

doi:10.4239/wjd.v15.i2.232

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1692)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

WORD

HTML

965

Figures (1-1)

120

Tables (1-5)

113

Sum=1263

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

242

Sum=332

Feb 15, 2024 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. Feb 15, 2024; 15(2): 232-239
Published online Feb 15, 2024. doi: 10.4239/wjd.v15.i2.232

Open in New Tab Full Size Figure Download Figure

Figure 1 The receiver operating curve for carcinoembryonic antigen and cancer antigen 199. CA: Cancer antigen; CEA: Carcinoembryonic antigen.

Citation: Meng M, Shi LL. Serum tumor markers expression (CA199, CA242, and CEA) and its clinical implications in type 2 diabetes mellitus. World J Diabetes 2024; 15(2): 232-239
URL: https://www.wjgnet.com/1948-9358/full/v15/i2/232.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i2.232